Drinking coffee is a daily routine for many people. Supplement manufacturers have proposed adding powdered Cordyceps militaris, known for its ergogenic and immunostimulating properties, and Hericium erinaceus, known for its nerve growth factor (NGF)-stimulating properties, to coffee. The aim of this work was to compare the bioactive substances in three types of coffee: machine-brewed, instant, and traditionally brewed, prepared with the addition of H. erinaceus and C. militaris fruiting bodies. The analysis of bioactive substances was performed using AAS and RP-HPLC methods. Among the control samples of coffee, traditionally brewed coffee was the best source of bioelements. Considering the mushroom species tested, the best additional source of Mg, Zn, Cu, Na, K, and Ca was C. militaris. A slightly higher Fe content was determined for H. erinaceus. With the addition of C. militaris, the amounts of 4-feruloylquinic acid (18.6 mg/200 mL) and 3,5-di-caffeoylquinic acid (3.76 mg/200 mL) also increased. In conclusion, the C. militaris species has been proven to be a better source of bioactive substances as a coffee additive in the daily diet. The combination of brewed coffee and the tested mushrooms seems to be the most beneficial in terms of health-promoting effects.

The selection of plant-based substrates for mushroom cultivation is a key factor influencing their growth and metabolism. The aim of this study was to demonstrate, in an innovative approach, differences in the content of biologically active compounds, bioelements, and antioxidant properties of Hericium erinaceus (Bull.) Pers. cultivated on various plant-based substrates derived from waste materials, specifically hemp straw and beech sawdust. Another objective was to compare various extraction methods in terms of their impact on the concentration of these compounds. Elemental analysis was performed using the TXRF method, while bioactive constituents were determined using the DAD/UV RP-HPLC technique. The plant-based substrate and extraction method influenced the levels of obtained metabolites. Dual extraction with moderate ethanol concentrations was most effective for isolating key bioactive compounds from H. erinaceus—notably ergothioneine, lovastatin, L-phenylalanine, and ergosterol—while antioxidant activity did not correlate with the concentration of the solvent used. Although dual extracts enhanced certain antioxidants and metabolites, whole fruiting bodies contained higher levels of bioelements. Overall, fruiting bodies grown on beech sawdust had greater amounts of most bioactive compounds compared to those cultivated on hemp straw, emphasizing that both substrate choice and extraction method critically influence the mushroom’s bioactive profile and its potential health benefits.

Osteoporosis is a metabolic disease of the skeleton characterized by a low bone mass and deterioration of bone tissue structure, leading to increased fragility and susceptibility to fractures. It is often referred to as the “silent killer of bones” because it progresses without symptoms until a bone fracture occurs. Osteoporosis is a serious health problem, especially in aging societies, leading to fractures, limited mobility, and a decreased quality of life. Osteoporosis prevention through dietary modification should be the first step in protecting bone health before implementing any form of pharmacotherapy. The composition of the diet and nutritional patterns are considered the most important factors influencing the shaping of gut microbiota and its metabolites, which in turn affect the regulation of bone tissue metabolism. Mushrooms, as a source of vitamin D, can play a significant role in the prevention of osteoporosis. Additionally, the application of UV irradiation can rapidly increase the vitamin D₂ content in mushrooms. A review of currently available studies reveals that many mushroom species contain substances (Ca, P, Se) that support bone formation by promoting remineralization. Mushrooms also induce bone regeneration after osteoporosis by balancing their reconstruction. This review systematically integrates the latest research on the use of mushrooms in the prevention of osteoporosis. The most promising species in the prevention of osteoporosis include: Lentinula edodes, Ganoderma lucidum, Ophiocordyceps sinensis, Pleurotus eryngii, Antrodia camphorata, Auricularia auricula, Agaricus bisporus, and Grifola frondosa.

Fungal-derived compounds are attracting increasing interest in cosmetic science because of their chemical diversity, multifunctional biological activity, and suitability for controlled biotechnological production. Macrofungi produce a wide range of bioactive metabolites, including polysaccharides, phenolic compounds, terpenoids, sterols, and pigments, many of which exhibit antioxidant, anti-inflammatory, moisturizing, photoprotective, and barrier-supporting properties relevant to skin health. However, current research is largely limited to isolated metabolites and simplified in vitro models, whereas comparatively little attention has been paid to the performance of fungal-derived compounds in finished cosmetic formulations. In practice, cosmetic efficacy depends not only on biological activity but also on extraction methods, physicochemical stability, formulation compatibility, and delivery efficiency. This review examines fungal-derived bioactive compounds from the perspective of cosmetic formulation and industrial applicability. It discusses how cultivation conditions, extraction procedures, and formulation design influence stability, bioavailability, and cosmetic performance, and critically evaluates extraction technologies, fermentation systems, encapsulation strategies, lipid carriers, hydrogels, and nanoscale delivery platforms. The review also addresses major limitations, including oxidative instability, variability in metabolite composition, limited penetration of high-molecular-weight compounds, and insufficient standardization and clinical validation. Although fungal-derived compounds show considerable promise for multifunctional cosmetic formulations, their broader industrial application will require improved standardization, optimized formulation strategies, and robust clinical evaluation of efficacy and safety.